West Branch Capital LLC’s Eli Lilly & Co Position
Does West Branch Capital LLC own Eli Lilly & Co (LLY)? Yes — 8.7K shares worth $10M (+2.43% of its 13F portfolio) as of Q2 2026, up from 8.5K shares the prior filed quarter.
Position Value
$10M
Q2 2026
Shares
8.7K
% of Portfolio
+2.43%
Quarters Held
24
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 8.7K | $10M | +2.43% |
| Q1 2026 | 8.5K | $8M | +2.10% |
| Q4 2025 | 8.5K | $9M | +2.35% |
| Q3 2025 | 8.4K | $6M | +1.68% |
| Q2 2025 | 8.2K | $6M | +1.90% |
| Q1 2025 | 5.7K | $5M | +1.58% |
| Q4 2024 | 5.1K | $4M | +1.26% |
| Q3 2024 | 4.5K | $4M | +1.38% |
| Q2 2024 | 4.3K | $4M | +1.46% |
| Q1 2024 | 4.2K | $3M | +1.33% |
| Q4 2023 | 3.6K | $2M | +0.98% |
| Q3 2023 | 3.1K | $2M | +0.87% |
| Q2 2023 | 3.1K | $1M | +0.71% |
| Q1 2023 | 2.9K | $985,249 | +0.55% |
| Q4 2022 | 2.9K | $1M | +0.65% |
| Q3 2022 | 2.9K | $934,000 | +0.58% |
| Q2 2022 | 2.8K | $922,000 | +0.53% |
| Q1 2022 | 2.8K | $815,000 | +0.39% |
| Q4 2021 | 3.1K | $845,000 | +0.36% |
| Q3 2021 | 2.5K | $580,000 | +0.28% |
| Q2 2021 | 2.3K | $533,000 | +0.26% |
| Q1 2021 | 1.5K | $278,000 | +0.16% |
| Q3 2020 | 4.4K | $657,000 | +0.42% |
| Q2 2020 | 4.1K | $674,000 | +0.47% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See West Branch Capital LLC’s full portfolio or all institutional holders of LLY.